Huons Partners with BaroPharm to Strengthen Pharmacy Distribution of 'Nizoral'

Huons announced on the 18th that it has signed a partnership with BaroPharm to strengthen promotional and sales activities targeting pharmacies for the broad-spectrum antifungal agent 'Nizoral 2% Solution.'

BaroPharm is a company that provides total management solutions for pharmacies, starting with an integrated pharmaceutical ordering service launched in July 2021. It offers services such as integrated pharmaceutical ordering for pharmacists, operation of the BaroPharm brand store, out-of-stock restock notifications, and compensation for drug price reductions. Currently, over 16,000 pharmacies are subscribed.

Through this partnership, Huons plans to enhance promotional and sales activities targeting pharmacies. Although Nizoral has been known as an anti-dandruff shampoo since its domestic release in the 1990s, Huons explains that it is an effective over-the-counter drug for seborrheic dermatitis and tinea infections on the face and body, as well as for preventing recurrence.

Nizoral is a representative broad-spectrum antifungal agent that has been used worldwide, including in the United States, for over 30 years. In Korea, it has ranked first in sales for five consecutive years since 2018 in the over-the-counter antifungal drug category for skin diseases.

A Huons official stated, "By signing a pharmacy distribution partnership with BaroPharm, an opportunity has been created to strengthen marketing and sales targeting pharmacies," adding, "We will focus on expanding the recognized effects of Nizoral, known as a dandruff treatment drug, to seborrheic dermatitis through newly launched TV advertisements and the BaroPharm partnership."

This content was produced with the assistance of AI translation services.